Login
YF

Yu Fan

Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.

Portfolio value
$94.9M
Positions
6
Quarter ended
September 30, 2026
Filed
November 16, 2026

Reported portfolio value by quarter (24 quarters reported)

$108M $1.27M
Q4 20 Q1 22 Q2 23 Q3 24 Q4 25 Q3 26

$34.4M in Q4 2020 → $94.9M now. Hover for any quarter.

Holdings

As reported for the quarter ended September 30, 2026. Activity is the change in share count since the prior quarter's filing.

Holding % of portfolio Activity Shares Value
KM Kestra Med Technologies Ltd 68.0% Unchanged 2,282,519 $64.6M
Whitehawk Therapeutics Inc 19.1% Trimmed 0.7% 4,829,398 $18.2M
IS Inventiva Sa 5.8% Unchanged 1,500,000 $5.54M
Promis Neurosciences Inc 3.8% Unchanged 329,760 $3.58M
Perspective Therapeutics Inc 3.1% Unchanged 1,055,409 $2.9M
American Bitcoin Corp. 0.2% Trimmed 93% 20,538 $174K

Timeline of changes

What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.

Q3 2026

quarter ended September 30, 2026 · filed November 16, 2026

Company Action Shares changed Value of change % of portfolio
Alumis Inc Exited −252,672 −$7.11M —
Ceribell Inc Exited −342,398 −$6.66M —
American Bitcoin Corp. Trimmed −287,538 −$2.44M 0.2%
Whitehawk Therapeutics Inc Trimmed −31,916 −$120K 19.1%

Q2 2026

quarter ended June 30, 2026 · filed August 14, 2026

Company Action Shares changed Value of change % of portfolio
Alumis Inc Trimmed −524,173 −$14.8M 6.6%
Whitehawk Therapeutics Inc Added +2,791,314 +$12.8M 20.6%
Ceribell Inc Trimmed −207,050 −$4.03M 6.2%

Q1 2026

quarter ended March 31, 2026 · filed May 18, 2026

Company Action Shares changed Value of change % of portfolio
Perspective Therapeutics Inc New +1,055,409 +$4.4M 4.5%
Promis Neurosciences Inc New +329,760 +$4.19M 4.3%
American Bitcoin Corp. New +308,076 +$285K 0.3%
Alumis Inc Trimmed −12,773 −$281K 17.6%

Q4 2025

quarter ended December 31, 2025 · filed February 18, 2026

Company Action Shares changed Value of change % of portfolio
Ceribell Inc Trimmed −803,718 −$17.6M 13.1%
IS Inventiva Sa New +1,500,000 +$6.98M 7.6%

Q3 2025

quarter ended September 30, 2025 · filed November 14, 2025

Company Action Shares changed Value of change % of portfolio
Cargo Therapeutics Inc Exited −912,000 −$3.76M —

Q2 2025

quarter ended June 30, 2025 · filed August 14, 2025

Company Action Shares changed Value of change % of portfolio
Cg Oncology Inc Exited −163,456 −$4M —
Ceribell Inc Added +130,964 +$2.45M 34.6%
Castle Biosciences Inc Exited −22,503 −$451K —
Sagimet Biosciences Inc Exited −57,190 −$186K —
PO Pyxis Oncology Inc Exited −69,303 −$67.9K —

Q1 2025

quarter ended March 31, 2025 · filed May 15, 2025

Company Action Shares changed Value of change % of portfolio
KM Kestra Med Technologies Ltd New +2,282,519 +$56.9M 58.5%
Whitehawk Therapeutics Inc New +2,070,000 +$3.68M 3.8%

Q4 2024

quarter ended December 31, 2024 · filed February 14, 2025

Company Action Shares changed Value of change % of portfolio
Ceribell Inc New +1,222,202 +$31.6M 59.4%

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support